Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

BIZARRE: 2 | Mind Blowing Facts

Do Wall Street Analysts Like Pentair Stock?

While Pentair has slightly outperformed the broader market over the past year, Wall Street analysts are reasonably bullish about the stock's potential.

What to Expect From Pentair's Q2 2024 Earnings Report

What to Expect From Pentair's Q2 2024 Earnings Report

Pentair is expected to release its second-quarter earnings later this month, and analysts project a double-digit earnings growth.

Analyst Ratings for Pentair

Analyst Ratings for Pentair

Within the last quarter, Pentair (NYSE:PNR) has observed the following analyst ratings:

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2022

Analyst Ratings for Pentair

Within the last quarter, Pentair (NYSE:PNR) has observed the following analyst ratings:

Pentair: Q1 Earnings Insights

Pentair (NYSE:PNR) reported its Q1 earnings results on Thursday, April 21, 2022 at 06:55 AM. Here's what investors need to know about the announcement.

Pentair's Earnings Outlook

Pentair (NYSE:PNR) is set to give its latest quarterly earnings report on Thursday, 2022-04-21. Here's what investors need to know before the announcement. Analysts estimate that Pentair will report an earnings per share (EPS) of $0.81.

inkl

Read news from The Economist, FT, and more,
with one subscription

Expert Ratings for Pentair

Expert Ratings for Pentair

Over the past 3 months, 6 analysts have published their opinion on Pentair (NYSE:PNR) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Mizuho Upgrades This Water Treatment Company - Read Why

Mizuho Upgrades This Water Treatment Company - Read Why

Mizuho analyst Brett Linzey upgraded Pentair PLC (NYSE:PNR) to Neutral from Underperform and raised the price target to $62 (an upside of 7%) from $60. The company's purchase of Manitowoc Ice business for a net price of $1.38 billion strengthens its commercial water franchise and should be meaningfully accretive to margins, states Linzey. Pentair recently agreed…

Analyst Ratings For Pentair

Analyst Ratings For Pentair

Within the last quarter, Pentair (NYSE:PNR) has observed the following analyst ratings:

Analyst Ratings For Pentair

Analyst Ratings For Pentair

Over the past 3 months, 4 analysts have published their opinion on Pentair (NYSE:PNR) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Pentair Clocks 24% Sales Growth In Q4; Sees Q1 EPS Below Consensus

Pentair Clocks 24% Sales Growth In Q4; Sees Q1 EPS Below Consensus

Pentair PLC (NYSE:PNR) reported fourth-quarter net sales growth of 24.2% year-over-year to $988.6 million and core sales growth of 19%, beating the consensus of $943.58 million. Consumer Solutions sales were up 31% Y/Y to $630 million, and return on sales was 21.6%, a decrease of 410 bps. Industrial & Flow Technologies sales were…

Pentair's Earnings Outlook

Pentair's Earnings Outlook

Pentair (NYSE:PNR) is set to give its latest quarterly earnings report on Tuesday, 2022-02-01. Here's what investors need to know before the announcement. Analysts estimate that Pentair will likely report an Earnings Per Share (EPS) of $0.85.

Will Chart Analysts Notice Bad Omen on Pentair's Chart

Will Chart Analysts Notice Bad Omen on Pentair's Chart

If history is any guide, there may be trouble ahead for shares of Pentair (NYSE:PNR). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Get all your
news in one place.

100's of premium titles.
One news app.

1 2

Organisations

FreeportMcMoRan

Keefe Bruyette & Woods

Ollie Bargain Outlet

Scotts Miracle Gro

Rigel Pharmaceuticals

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Places

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play